other material
confidence high
sentiment neutral
materiality 0.75
Mangoceuticals raises $900k via Series B Preferred and warrants for 1.188M shares
MANGOCEUTICALS, INC.
- Closed four SPAs from Dec 31, 2024 through Jan 6, 2025, selling 900 shares of Series B Preferred at $1,000 each for $900k total.
- Issued warrants to purchase up to 1,188,000 shares, exercisable at 105% of 10-day VWAP (range $2.57–$2.61), 5-year term.
- Warrants exercisable after 180 days; include dilutive issuance price adjustments and cashless exercise if registration not effective.
- Series B Preferred convertible at $1,100 stated value, floor price $2.25; 440,000 common shares issuable on full conversion.
- Offering of 1,250 Series B Preferred shares closed; securities issued under Section 4(a)(2)/Reg D, no public offering.